Healthcare provider profile · identity verified

John Maxwell Carment, MD

Geriatric Medicine · TULSA, OK · NPI 1013129329

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	505	86
Furosemide	Furosemide	420	65
Atorvastatin Calcium	Atorvastatin Calcium	350	88
Eliquis	Apixaban	326	38
Amlodipine Besylate	Amlodipine Besylate	305	80
Gabapentin	Gabapentin	284	64
Omeprazole	Omeprazole	248	56
Pantoprazole Sodium	Pantoprazole Sodium	243	52
Losartan Potassium	Losartan Potassium	228	51
Potassium Chloride	Potassium Chloride	220	50
Lisinopril	Lisinopril	194	49
Mirtazapine	Mirtazapine	157	32
Tamsulosin Hcl	Tamsulosin Hcl	152	29
Metoprolol Succinate	Metoprolol Succinate	146	37
Sertraline Hcl	Sertraline Hcl	143	32
Alendronate Sodium	Alendronate Sodium	134	27
Memantine Hcl	Memantine Hcl	134	23
Carvedilol	Carvedilol	131	24
Duloxetine Hcl	Duloxetine Hcl	128	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	121	39
Escitalopram Oxalate	Escitalopram Oxalate	110	26
Famotidine	Famotidine	109	23
Trazodone Hcl	Trazodone Hcl	109	32
Quetiapine Fumarate	Quetiapine Fumarate	104	16
Lorazepam	Lorazepam	100	26
Metoprolol Tartrate	Metoprolol Tartrate	89	20
Donepezil Hcl	Donepezil Hcl	88	23
Fluticasone Propionate	Fluticasone Propionate	87	29
Montelukast Sodium	Montelukast Sodium	87	15
Finasteride	Finasteride	85	15
Hydrochlorothiazide	Hydrochlorothiazide	83	22
Xarelto	Rivaroxaban	83	suppressed
Torsemide	Torsemide	82	21
Rosuvastatin Calcium	Rosuvastatin Calcium	81	22
Pravastatin Sodium	Pravastatin Sodium	78	19
Clonazepam	Clonazepam	72	suppressed
Meloxicam	Meloxicam	68	16
Carbidopa-Levodopa	Carbidopa/Levodopa	64	suppressed
Clopidogrel	Clopidogrel Bisulfate	63	17
Citalopram Hbr	Citalopram Hydrobromide	62	12
Metformin Hcl	Metformin Hcl	62	16
Tramadol Hcl	Tramadol Hcl	59	18
Triamcinolone Acetonide	Triamcinolone Acetonide	58	25
Venlafaxine Hcl Er	Venlafaxine Hcl	58	12
Prednisone	Prednisone	57	21
Cephalexin	Cephalexin	55	36
Simvastatin	Simvastatin	54	14
Pregabalin	Pregabalin	49	suppressed
Bupropion Xl	Bupropion Hcl	48	12
Gemtesa	Vibegron	47	suppressed
Levetiracetam	Levetiracetam	47	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	46	12
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Allopurinol	Allopurinol	43	13
Olanzapine	Olanzapine	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Myrbetriq	Mirabegron	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	17
Ondansetron Hcl	Ondansetron Hcl	38	31
Spironolactone	Spironolactone	38	14
Latanoprost	Latanoprost	37	suppressed
Chlorthalidone	Chlorthalidone	36	suppressed
Digoxin	Digoxin	36	suppressed
Rivastigmine	Rivastigmine	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Divalproex Sodium	Divalproex Sodium	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Hydrocortisone	Hydrocortisone	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Ozempic	Semaglutide	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	21
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Estradiol	Estradiol	28	11
Farxiga	Dapagliflozin Propanediol	27	suppressed
Topiramate	Topiramate	27	suppressed
Azithromycin	Azithromycin	26	19
Benazepril Hcl	Benazepril Hcl	26	suppressed
Colestipol Hcl	Colestipol Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Nystatin	Nystatin	26	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	24	suppressed
Enulose	Lactulose	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	15
Aripiprazole	Aripiprazole	23	11
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Linzess	Linaclotide	23	suppressed
Movantik	Naloxegol Oxalate	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Restasis	Cyclosporine	23	suppressed
Glipizide	Glipizide	22	suppressed
Levofloxacin	Levofloxacin	22	13
Risperidone	Risperidone	22	suppressed
Fluconazole	Fluconazole	21	11
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Sucralfate	Sucralfate	19	suppressed
Trospium Chloride	Trospium Chloride	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Folic Acid	Folic Acid	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Atenolol	Atenolol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Cefdinir	Cefdinir	15	13
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Cabergoline	Cabergoline	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Combigan	Brimonidine Tartrate/Timolol	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Diazepam	Diazepam	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan	Valsartan	13	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nyamyc	Nystatin	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Travoprost	Travoprost	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pindolol	Pindolol	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error